Recently, the 4th Belt and Road Publishing Cooperation Experience Exchange Conference sponsored by the China Publishing Association and China Publishing Group was held in Chengdu, Sichuan Province. The output project ofInternational Clinical Medicine Series under the Background of 'Belt and Road'by ZZU Press was selected as one of the typical "Belt and Road" publishing cooperation cases announc...
Recently, the Recombinant Human nsIL12 Oncolytic Adenovirus Injection has obtained the approval by the NMPA for the clinical trial of Class I new drugs. The injection was jointly developed by the research team of Prof. Wang Pengju and Academician Nick Lemmon from the Sino-British Molecular Oncology Research Center of ZZU, and the International Joint Research Center of National Cell and Gene The...
The first ChinaNanoenzyme Summit Forumhas recentlyopened in Zhengzhou, Henan Province.Experts and scholars in this fieldattended the Summit, among whom were professorYan XiyunandChen Runshengwho arealsoacademiciansof Chinese Academy of Sciences,Li Ming, member of the Royal Society of Canada
Professor Jiang Binghua from School of Medical Scienceshasmade new progress inhis research onnon-small-cell lung carcinoma resistance.The research result, entitled "Elevated NOX4 Promotes Tumorigenesis and Acquired EGFR-TKIs Resistance via Enhancing IL-8/PD-L1 Signaling in NSCLC"is published in theleadingacademic journalDrug Resistance Updates